Nicholas A. Saccomano

Saccoman, a biopharmaceutical professional, currently is a scientific advisor to Entos Inc., Dyve Biosciences, and Volastra Therapeutics. He previously served as chief science officer and SVP at Pfizer, chief science officer at Array BioPharma, and chief technology officer at SomaLogic.

  • March 2022

Added to: OnKure Therapeutics Inc. - Boulder , CO

OnKure is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.